Choroidal Neovascularization Market Report 2026
Download Free Sample Buy Now
Choroidal Neovascularization Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Choroidal Neovascularization Market Report 2026

Global Outlook – By Treatment Type (Anti-Angiogenic Therapy, Laser Photocoagulation, Photodynamic Therapy, Verteporfin Sodium, Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium), By Indication (Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Central Serous Chorioretinopathy (CSC), Polypoidal Choroidal Vasculopathy (PCV), Myopic Macular Degeneration (MMD), Other Indications), By Route Of Administration (Intravitreal, Subconjunctival, Periocular, Oral), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Research Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Choroidal Neovascularization Market Overview

• Choroidal Neovascularization market size has reached to $4.18 billion in 2025

• Expected to grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%

• Growth Driver: Increasing Prevalence Of Age-related Macular Degeneration Driving Market Growth

• Market Trend: Advancements In Treatment For Eye Disease With Photodynamic Therapy

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Choroidal Neovascularization Market?

Choroidal neovascularization (CNV) is the abnormal growth of blood vessels in the choroid layer of the eye, often extending into the retina. These newly formed blood vessels are fragile and prone to leaking fluid or blood, which can damage the retinal tissues, leading to vision distortion or loss.

The main treatment types of choroidal neovascularization are anti-angiogenic therapy, laser photocoagulation, photodynamic therapy, verteporfin sodium, ranibizumab, bevacizumab, aflibercept, and pegaptanib sodium. Anti-angiogenic therapy is a treatment that inhibits the formation of new blood vessels (angiogenesis), which can help prevent the growth of abnormal blood vessels. These treatments are commonly used based on the specific indications such as age-related macular degeneration (AMD), diabetic macular edema (DME), central serous chorioretinopathy (CSC), polypoidal choroidal vasculopathy (PCV), myopic macular degeneration (MMD), and other related conditions. The route of administration can vary, with options including intravitreal, subconjunctival, periocular, or oral administration. These therapies are primarily administered in hospitals, ophthalmology clinics, and ambulatory surgical centers.

Choroidal Neovascularization Market Global Report 2026 Market Report bar graph

What Is The Choroidal Neovascularization Market Size and Share 2026?

The choroidal neovascularization market size has grown strongly in recent years. It will grow from $4.18 billion in 2025 to $4.5 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing prevalence of age-related macular degeneration, rising diabetic eye disease cases, expansion of ophthalmology clinics, availability of anti-angiogenic drugs, improved retinal diagnostic capabilities.

What Is The Choroidal Neovascularization Market Growth Forecast?

The choroidal neovascularization market size is expected to see strong growth in the next few years. It will grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing aging population, rising focus on early ophthalmic intervention, expansion of combination therapy approaches, growing investments in retinal disease research, increasing adoption of personalized treatment protocols. Major trends in the forecast period include increasing adoption of anti-vegf therapies, rising use of treat-and-extend regimens, growing demand for early cnv diagnosis, expansion of advanced retinal imaging techniques, enhanced focus on vision preservation therapies.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Choroidal Neovascularization Market Segmentation

1) By Treatment Type: Anti-Angiogenic Therapy, Laser Photocoagulation, Photodynamic Therapy, Verteporfin Sodium, Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium

2) By Indication: Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Central Serous Chorioretinopathy (CSC), Polypoidal Choroidal Vasculopathy (PCV), Myopic Macular Degeneration (MMD), Other Indications

3) By Route Of Administration: Intravitreal, Subconjunctival, Periocular, Oral

4) By End User: Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Research Centers

Subsegments:

1) By Anti-Angiogenic Therapy (Anti-VEGF Therapy): Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium

2) By Laser Photocoagulation: Thermal Laser Photocoagulation, MicroPulse Laser Therapy

3) By Photodynamic Therapy (PDT): Standard PDT, Low-Fluence PDT, Half-Dose PDT

4) By Verteporfin Sodium: Intravenous Administration, Combination Therapy With Anti-VEGF

5) By Ranibizumab: Monthly Dosing, As-Needed Dosing, Treat-and-Extend Regimen

6) By Bevacizumab: Off-Label Use, Compounded Intravitreal Injections

7) By Aflibercept: Fixed-Dosing Regimen, Treat-and-Extend Regimen

8) By Pegaptanib Sodium: Monotherapy, Combination Therapy

What Is The Driver Of The Choroidal Neovascularization Market?

The rising prevalence of age-related macular degeneration (AMD) is expected to propel the growth of the choroidal neovascularization (CNV) market going forward. Age-related macular degeneration (AMD) is an eye disease that gradually damages the macula, leading to central vision loss, primarily in older adults. The rising prevalence of age-related macular degeneration (AMD) is due to the aging population, increased life expectancy, lifestyle changes, genetic factors, and greater exposure to environmental risks. Choroidal neovascularization (CNV) supports age-related macular degeneration (AMD) patients by contributing to the development of wet AMD, where the growth of abnormal blood vessels beneath the retina leads to vision deterioration, requiring advanced treatments such as anti-VEGF therapy to manage choroidal neovascularization (CNV) and slow the progression of age-related macular degeneration (AMD), ultimately preserving central vision in affected individuals. For instance, in 2025, according to the UHN Foundation, Canada-Based official fundraising arm, age-related macular degeneration (AMD) is the primary cause of significant, irreversible vision loss in individuals over 50. Currently affecting over 200 million people globally, this number is projected to rise to 288 million by 2040. Therefore, the increasing prevalence of age-related macular degeneration is driving the growth of the choroidal neovascularization industry.

Key Players In The Global Choroidal Neovascularization Market

Major companies operating in the choroidal neovascularization market are Roche Holding AG, Regeneron Pharmaceuticals Incorporated, Bayer Aktiengesellschaft, Novartis AG, Apellis Pharmaceuticals Incorporated, Kodiak Sciences Incorporated, Adverum Biotechnologies Incorporated, Clearside Biomedical Incorporated, Graybug Vision Incorporated, Outlook Therapeutics Incorporated, Oxurion NV, 4D Molecular Therapeutics Incorporated, Opthea Limited, Eyepoint Pharmaceuticals Incorporated, Ocular Therapeutix Incorporated, OcuTerra Therapeutics Incorporated, Ocuphire Pharma Incorporated, Kubota Vision Incorporated, Amgen Incorporated, Coherus BioSciences Incorporated, Formycon AG, Alimera Sciences Incorporated, Neurotech Pharmaceuticals Incorporated, Alkeus Pharmaceuticals Incorporated, Aerie Pharmaceuticals Incorporated, Acucela Incorporated

Global Choroidal Neovascularization Market Trends and Insights

Major companies operating in the choroidal neovascularization market are focusing on developing innovative therapies, such as photodynamic therapy, to provide eye care professionals with precise, efficient treatment options that improve patient outcomes and treatment delivery. Photodynamic therapy (PDT) is a medical treatment that uses a photosensitizing agent activated by light to target and destroy abnormal or cancerous cells. For instance, in February 2023, Bausch & Lomb, a Canada-based healthcare company, and Modulight, a Finland-based biomedical company, announced the ML6710i photodynamic laser approved by the Food and Drug Administration, a US-based federal agency. This therapy is approved for the use with Bausch + Lomb’s VISUDYNE therapy, designed to treat choroidal neovascularization caused by age-related macular degeneration (AMD). This modern, mobile ophthalmic laser offers a targeted approach to treating abnormal blood vessels in the eye, helping to prevent further disease progression and preserve vision.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Choroidal Neovascularization Market?

In March 2024, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired CIMERLI business from Coherus for $170 Million. With this acquisition, Sandoz Group AG aims to expand its portfolio in the ophthalmic sector by acquiring the CIMERLI business from Coherus, enhancing its ability to offer innovative treatments for retinal diseases, such as age-related macular degeneration (AMD). Coherus BioSciences is a US-based biopharmaceutical company that focuses on the research and development of diseases such as choroidal neovascularization.

Regional Outlook

North America was the largest region in the choroidal neovascularization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Choroidal Neovascularization Market?

The choroidal neovascularization market consists of revenues earned by entities by providing services such as diagnostic services, therapeutic services, and follow-up and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The choroidal neovascularization market also includes sales of injections, therapy agents, and surgical & laser devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Choroidal Neovascularization Market Report 2026?

The choroidal neovascularization market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the choroidal neovascularization industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Choroidal Neovascularization Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.5 billion
Revenue Forecast In 2035 $5.99 billion
Growth Rate CAGR of 7.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Indication, Route Of Administration, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Roche Holding AG, Regeneron Pharmaceuticals Incorporated, Bayer Aktiengesellschaft, Novartis AG, Apellis Pharmaceuticals Incorporated, Kodiak Sciences Incorporated, Adverum Biotechnologies Incorporated, Clearside Biomedical Incorporated, Graybug Vision Incorporated, Outlook Therapeutics Incorporated, Oxurion NV, 4D Molecular Therapeutics Incorporated, Opthea Limited, Eyepoint Pharmaceuticals Incorporated, Ocular Therapeutix Incorporated, OcuTerra Therapeutics Incorporated, Ocuphire Pharma Incorporated, Kubota Vision Incorporated, Amgen Incorporated, Coherus BioSciences Incorporated, Formycon AG, Alimera Sciences Incorporated, Neurotech Pharmaceuticals Incorporated, Alkeus Pharmaceuticals Incorporated, Aerie Pharmaceuticals Incorporated, Acucela Incorporated
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Choroidal Neovascularization Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Choroidal Neovascularization Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Choroidal Neovascularization Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Choroidal Neovascularization Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Anti-Vegf Therapies

4.2.2 Rising Use Of Treat-And-Extend Regimens

4.2.3 Growing Demand For Early Cnv Diagnosis

4.2.4 Expansion Of Advanced Retinal Imaging Techniques

4.2.5 Enhanced Focus On Vision Preservation Therapies

5. Choroidal Neovascularization Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Ophthalmology Clinics

5.3 Ambulatory Surgical Centers

5.4 Eye Specialty Hospitals

5.5 Research Centers

6. Choroidal Neovascularization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Choroidal Neovascularization Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Choroidal Neovascularization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Choroidal Neovascularization Market Size, Comparisons And Growth Rate Analysis

7.3. Global Choroidal Neovascularization Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Choroidal Neovascularization Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Choroidal Neovascularization Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Choroidal Neovascularization Market Segmentation

9.1. Global Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-Angiogenic Therapy, Laser Photocoagulation, Photodynamic Therapy, Verteporfin Sodium, Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium

9.2. Global Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Central Serous Chorioretinopathy (CSC), Polypoidal Choroidal Vasculopathy (PCV), Myopic Macular Degeneration (MMD), Other Indications

9.3. Global Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravitreal, Subconjunctival, Periocular, Oral

9.4. Global Choroidal Neovascularization Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers, Research Centers

9.5. Global Choroidal Neovascularization Market, Sub-Segmentation Of Anti-Angiogenic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ranibizumab, Bevacizumab, Aflibercept, Pegaptanib Sodium

9.6. Global Choroidal Neovascularization Market, Sub-Segmentation Of Laser Photocoagulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Thermal Laser Photocoagulation, MicroPulse Laser Therapy

9.7. Global Choroidal Neovascularization Market, Sub-Segmentation Of Photodynamic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard PDT, Low-Fluence PDT, Half-Dose PDT

9.8. Global Choroidal Neovascularization Market, Sub-Segmentation Of Verteporfin Sodium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous Administration, Combination Therapy With Anti-VEGF

9.9. Global Choroidal Neovascularization Market, Sub-Segmentation Of Ranibizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monthly Dosing, As-Needed Dosing, Treat-and-Extend Regimen

9.10. Global Choroidal Neovascularization Market, Sub-Segmentation Of Bevacizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Off-Label Use, Compounded Intravitreal Injections

9.11. Global Choroidal Neovascularization Market, Sub-Segmentation Of Aflibercept, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fixed-Dosing Regimen, Treat-and-Extend Regimen

9.12. Global Choroidal Neovascularization Market, Sub-Segmentation Of Pegaptanib Sodium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monotherapy, Combination Therapy

10. Choroidal Neovascularization Market Regional And Country Analysis

10.1. Global Choroidal Neovascularization Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Choroidal Neovascularization Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Choroidal Neovascularization Market

11.1. Asia-Pacific Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Choroidal Neovascularization Market

12.1. China Choroidal Neovascularization Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Choroidal Neovascularization Market

13.1. India Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Choroidal Neovascularization Market

14.1. Japan Choroidal Neovascularization Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Choroidal Neovascularization Market

15.1. Australia Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Choroidal Neovascularization Market

16.1. Indonesia Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Choroidal Neovascularization Market

17.1. South Korea Choroidal Neovascularization Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Choroidal Neovascularization Market

18.1. Taiwan Choroidal Neovascularization Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Choroidal Neovascularization Market

19.1. South East Asia Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Choroidal Neovascularization Market

20.1. Western Europe Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Choroidal Neovascularization Market

21.1. UK Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Choroidal Neovascularization Market

22.1. Germany Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Choroidal Neovascularization Market

23.1. France Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Choroidal Neovascularization Market

24.1. Italy Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Choroidal Neovascularization Market

25.1. Spain Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Choroidal Neovascularization Market

26.1. Eastern Europe Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Choroidal Neovascularization Market

27.1. Russia Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Choroidal Neovascularization Market

28.1. North America Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Choroidal Neovascularization Market

29.1. USA Choroidal Neovascularization Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Choroidal Neovascularization Market

30.1. Canada Choroidal Neovascularization Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Choroidal Neovascularization Market

31.1. South America Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Choroidal Neovascularization Market

32.1. Brazil Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Choroidal Neovascularization Market

33.1. Middle East Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Choroidal Neovascularization Market

34.1. Africa Choroidal Neovascularization Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Choroidal Neovascularization Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Choroidal Neovascularization Market Regulatory and Investment Landscape

36. Choroidal Neovascularization Market Competitive Landscape And Company Profiles

36.1. Choroidal Neovascularization Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Choroidal Neovascularization Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Choroidal Neovascularization Market Company Profiles

36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Regeneron Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Apellis Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Choroidal Neovascularization Market Other Major And Innovative Companies

Kodiak Sciences Incorporated, Adverum Biotechnologies Incorporated, Clearside Biomedical Incorporated, Graybug Vision Incorporated, Outlook Therapeutics Incorporated, Oxurion NV, 4D Molecular Therapeutics Incorporated, Opthea Limited, Eyepoint Pharmaceuticals Incorporated, Ocular Therapeutix Incorporated, OcuTerra Therapeutics Incorporated, Ocuphire Pharma Incorporated, Kubota Vision Incorporated, Amgen Incorporated, Coherus BioSciences Incorporated

38. Global Choroidal Neovascularization Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Choroidal Neovascularization Market

40. Choroidal Neovascularization Market High Potential Countries, Segments and Strategies

40.1 Choroidal Neovascularization Market In 2030 - Countries Offering Most New Opportunities

40.2 Choroidal Neovascularization Market In 2030 - Segments Offering Most New Opportunities

40.3 Choroidal Neovascularization Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Choroidal Neovascularization Market, Overview Of Key Products - Product Examples
  • Table 2: Global Choroidal Neovascularization Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Choroidal Neovascularization Market, Supply Chain Analysis
  • Table 4: Global Choroidal Neovascularization Market, Major Raw Material Providers
  • Table 5: Global Choroidal Neovascularization Market, Major Resource Providers
  • Table 6: Global Choroidal Neovascularization Market, Major Manufacturers (Suppliers)
  • Table 7: Global Choroidal Neovascularization Market, Major Distributors And Channel Partners
  • Table 8: Global Choroidal Neovascularization Market, Key Technologies & Future Trends
  • Table 9: Global Choroidal Neovascularization Market, Major Trends
  • Table 10: Global Choroidal Neovascularization Market, Major End Users
  • Table 11: Global Choroidal Neovascularization Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Choroidal Neovascularization Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Choroidal Neovascularization Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Choroidal Neovascularization Market - TAM, US$ Billion, 2025
  • Table 15: Global Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Choroidal Neovascularization Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Choroidal Neovascularization Market, Sub-Segmentation Of Anti-Angiogenic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Choroidal Neovascularization Market, Sub-Segmentation Of Laser Photocoagulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Choroidal Neovascularization Market, Sub-Segmentation Of Photodynamic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Choroidal Neovascularization Market, Sub-Segmentation Of Verteporfin Sodium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Choroidal Neovascularization Market, Sub-Segmentation Of Ranibizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Choroidal Neovascularization Market, Sub-Segmentation Of Bevacizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Choroidal Neovascularization Market, Sub-Segmentation Of Aflibercept, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Choroidal Neovascularization Market, Sub-Segmentation Of Pegaptanib Sodium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Global Choroidal Neovascularization Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Global Choroidal Neovascularization Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: China, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: China, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: India, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: India, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Japan, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Japan, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Australia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Australia, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Indonesia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Indonesia, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South Korea, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South Korea, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Taiwan, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Taiwan, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: South East Asia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: South East Asia, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Western Europe, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Western Europe, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: UK, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: UK, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Germany, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Germany, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: France, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: France, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Italy, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Italy, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Spain, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Spain, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Russia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Russia, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: North America, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: North America, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: USA, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: USA, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Canada, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Canada, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: South America, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: South America, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Brazil, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Brazil, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Middle East, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Middle East, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Africa, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 100: Africa, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 101: Global Choroidal Neovascularization Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 102: Global Choroidal Neovascularization Market - Company Scoring Matrix
  • Table 103: Roche Holding AG Financial Performance
  • Table 104: Regeneron Pharmaceuticals Incorporated Financial Performance
  • Table 105: Bayer Aktiengesellschaft Financial Performance
  • Table 106: Novartis AG Financial Performance
  • Table 107: Apellis Pharmaceuticals Incorporated Financial Performance
  • Table 108: Global Choroidal Neovascularization Market, Competitive Benchmarking (In USD Billions)
  • Table 109: Global Choroidal Neovascularization Market, Competitive Dashboard
  • Table 110: Global Choroidal Neovascularization Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 111: Global, Choroidal Neovascularization Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 112: Global, Choroidal Neovascularization Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 113: Global, Choroidal Neovascularization Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Choroidal Neovascularization Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Choroidal Neovascularization Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Choroidal Neovascularization Market, Supply Chain Analysis
  • Figure 4: Global Choroidal Neovascularization Market, Major Raw Material Providers
  • Figure 5: Global Choroidal Neovascularization Market, Major Resource Providers
  • Figure 6: Global Choroidal Neovascularization Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Choroidal Neovascularization Market, Major Distributors And Channel Partners
  • Figure 8: Global Choroidal Neovascularization Market, Key Technologies & Future Trends
  • Figure 9: Global Choroidal Neovascularization Market, Major Trends
  • Figure 10: Global Choroidal Neovascularization Market, Major End Users
  • Figure 11: Global Choroidal Neovascularization Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Choroidal Neovascularization Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Choroidal Neovascularization Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Choroidal Neovascularization Market - TAM, US$ Billion, 2025
  • Figure 15: Global Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Choroidal Neovascularization Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Choroidal Neovascularization Market, Sub-Segmentation Of Anti-Angiogenic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Choroidal Neovascularization Market, Sub-Segmentation Of Laser Photocoagulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Choroidal Neovascularization Market, Sub-Segmentation Of Photodynamic Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Choroidal Neovascularization Market, Sub-Segmentation Of Verteporfin Sodium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Choroidal Neovascularization Market, Sub-Segmentation Of Ranibizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Choroidal Neovascularization Market, Sub-Segmentation Of Bevacizumab, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Choroidal Neovascularization Market, Sub-Segmentation Of Aflibercept, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Choroidal Neovascularization Market, Sub-Segmentation Of Pegaptanib Sodium, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Global Choroidal Neovascularization Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Global Choroidal Neovascularization Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Asia-Pacific, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: China, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: China, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: India, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: India, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Japan, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Japan, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Australia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Australia, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Indonesia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Indonesia, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South Korea, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South Korea, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Taiwan, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Taiwan, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: South East Asia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: South East Asia, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Western Europe, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Western Europe, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: UK, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: UK, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Germany, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Germany, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: France, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: France, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Italy, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Italy, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Spain, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Spain, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Eastern Europe, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Russia, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Russia, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: North America, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: North America, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: USA, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: USA, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Canada, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Canada, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: South America, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: South America, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Brazil, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Brazil, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Middle East, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Middle East, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Choroidal Neovascularization Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Africa, Choroidal Neovascularization Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 100: Africa, Choroidal Neovascularization Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 101: Global Choroidal Neovascularization Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 102: Global Choroidal Neovascularization Market - Company Scoring Matrix
  • Figure 103: Roche Holding AG Financial Performance
  • Figure 104: Regeneron Pharmaceuticals Incorporated Financial Performance
  • Figure 105: Bayer Aktiengesellschaft Financial Performance
  • Figure 106: Novartis AG Financial Performance
  • Figure 107: Apellis Pharmaceuticals Incorporated Financial Performance
  • Figure 108: Global Choroidal Neovascularization Market, Competitive Benchmarking (In USD Billions)
  • Figure 109: Global Choroidal Neovascularization Market, Competitive Dashboard
  • Figure 110: Global Choroidal Neovascularization Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 111: Global, Choroidal Neovascularization Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 112: Global, Choroidal Neovascularization Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 113: Global, Choroidal Neovascularization Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Ocular Drug Delivery Market Report 2026 - Global Outlook – By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies), By Formulati...

Intravascular Ultrasound Market Report 2026 - Global Outlook – By Type (Platform Intravascular Ultrasound, Compact Intravascular Ultrasound), By Modality (Virtual Histology Intravascular Ultrasound (IVUS), iMap Intravasc...

Vascular Imaging Market Report 2026 - Global Outlook – By Technique (Magnetic Resonance Imaging, Ultrasound, Computed Tomography, Nuclear Imaging, X-Ray), By Procedure (Coronary Angiography, Peripheral Angiography, Neuro...

Ocular Hypertension Treatment Market Report 2026 - Global Outlook – By Type (Intraocular Hypertension, Glaucoma), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By Distribution Channel (Ho...

Peripheral Artery Disease Market Report 2026 - Global Outlook – By Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynami...

Vascular Imaging Devices Market Report 2026 - Global Outlook – By Type (Minimally Invasive, Non-Invasive), By Application (Diagnostics, Therapeutics), By End-User (Hospitals, Diagnostic Imaging Centers, Other End Users) ...

Neurovascular Embolization Devices Market Report 2026 - Global Outlook – By Product (Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products), By Treatment (Neurovascular Hemorrh...

Peripheral Arterial Disease Market Report 2026 - Global Outlook – By Treatment Type (Devices, Catheters, Drugs, Other Types), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End User (Ho...

Frequently Asked Questions

The Choroidal Neovascularization market was valued at $4.18 billion in 2025, increased to $4.5 billion in 2026, and is projected to reach $5.99 billion by 2030.

The global Choroidal Neovascularization market is expected to grow at a CAGR of 7.4% from 2026 to 2035 to reach $5.99 billion by 2035.

Some Key Players in the Choroidal Neovascularization market Include, Roche Holding AG, Regeneron Pharmaceuticals Incorporated, Bayer Aktiengesellschaft, Novartis AG, Apellis Pharmaceuticals Incorporated, Kodiak Sciences Incorporated, Adverum Biotechnologies Incorporated, Clearside Biomedical Incorporated, Graybug Vision Incorporated, Outlook Therapeutics Incorporated, Oxurion NV, 4D Molecular Therapeutics Incorporated, Opthea Limited, Eyepoint Pharmaceuticals Incorporated, Ocular Therapeutix Incorporated, OcuTerra Therapeutics Incorporated, Ocuphire Pharma Incorporated, Kubota Vision Incorporated, Amgen Incorporated, Coherus BioSciences Incorporated, Formycon AG, Alimera Sciences Incorporated, Neurotech Pharmaceuticals Incorporated, Alkeus Pharmaceuticals Incorporated, Aerie Pharmaceuticals Incorporated, Acucela Incorporated .

Major trend in this market includes: Advancements In Treatment For Eye Disease With Photodynamic Therapy. For further insights on this market. request a sample here

North America was the largest region in the choroidal neovascularization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the choroidal neovascularization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us